Chimeric Appoints Jennifer Chow as CEO & MD

Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), a clinical-stage cell therapy company, is pleased to announce the appointment of current Chief Operating Officer, Jennifer Chow, as Chief Executive Officer and Managing Director. Ms Chow has been Chief Operating Officer of Chimeric since November 2020. Prior to joining Chimeric, Ms Chow was Head of Global Marketing, Analytics and Commer